DIA Biosimilars 2013

Oncobiologics

Oncobiologics, inVentiv Health partner for biosimilars

Wednesday, August 7, 2013 11:43 AM

Privately-held biopharmaceutical company Oncobiologics and inVentiv Health have partnered around clinical development for all assets in Oncobiologic's pipeline. The global partnership will initially focus on biosimilar assets, and could be expanded to include innovative molecules.

More... »

Cenduit: Now with Patient Reminders

Oncobiologics signs two agreements worth $80 million

Thursday, October 13, 2011 12:50 PM

Oncobiologics has signed two major agreements. The first is with Parilis Biopharmaceuticals, an early-stage biotech company, and involves worldwide licensing for an undisclosed biotherapeutic product. The second is with a US based pharmaceutical company to conduct research focused on solving issues related to downstream processing of monoclonal antibodies. The identity of the client firm was not disclosed due to confidentiality terms in the agreement. The combined value of the agreements to Oncobiologics totals close to $80 million.

More... »

CRF Health – eCOA Forum

Oncobiologics names Canute to board of directors

Wednesday, October 12, 2011 11:31 AM

Oncobiologics has named Scott Canute to its board of directors.

More... »

Oncobiologics, Fox Chase Cancer Center to create cancer therapy platform

Monday, August 22, 2011 01:41 PM

Oncobiologics and Fox Chase Cancer Center have agreed to co-develop a novel, next-generation bi-specific antibody cancer platform with enhanced therapeutic capabilities against solid tumors. The jointly engineered platform is designed to handle multiple targets, representing a pipeline of promising cancer treatments. This research program is now underway, with preclinical studies expected in Q1-2012 for the first molecule using this platform.

More... »

CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

Copyright © 1995-2013 CenterWatch.